aStudent Research Committee, Tabriz University of Medical sciences, Faculty of Pharmacy, Tabriz, Iran

bDepartment of Pharmaceutical and Food Control, Tabriz University of Medical sciences, Faculty of Pharmacy, Tabriz, Iran

cDepartment of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

dNanora Pharmaceuticals, Tabriz, Iran.

Correspondence to Tooba Gholikhani, Pharm. D, Tabriz Medical University: Tabriz University of Medical Sciences, Tabriz, East Azerbaijan province, Islamic Republic of Iran. E-mail: [email protected]

Received 6 May, 2022

Accepted 6 August, 2022